These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10311841)

  • 1. Making your P & T Committee work for you.
    Lipman AG
    Hosp Formul; 1987 Jan; 22(1):103-4. PubMed ID: 10311841
    [No Abstract]   [Full Text] [Related]  

  • 2. Does your committee pass the McNemar test?
    Owen JA
    Hosp Formul; 1979 Jun; 14(6):605. PubMed ID: 10242200
    [No Abstract]   [Full Text] [Related]  

  • 3. The P&T Committee and cancer chemotherapy: Part II. Who should prescribe anticancer drugs.
    Krakoff IH
    Hosp Formul; 1982 Apr; 17(4):577-8. PubMed ID: 10254882
    [No Abstract]   [Full Text] [Related]  

  • 4. ASHP statement on the pharmacy and therapeutics committee.
    Am J Hosp Pharm; 1978 Jul; 35(7):813-4. PubMed ID: 665701
    [No Abstract]   [Full Text] [Related]  

  • 5. ASHP statement on the pharmacy and therapeutics committee.
    Am J Hosp Pharm; 1992 Aug; 49(8):2008-9. PubMed ID: 1442847
    [No Abstract]   [Full Text] [Related]  

  • 6. Editors' roundtable: current formulas for P & T Committee success. (Part 2).
    Lipman AG; Neu HC; Singh BN; Weintraub M
    Hosp Formul; 1987 Apr; 22(4):373-82. PubMed ID: 10281367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A call for fairness in formulary decisions.
    Levinson W; Laupacis A
    Arch Intern Med; 2006 Jan; 166(1):16-8. PubMed ID: 16401806
    [No Abstract]   [Full Text] [Related]  

  • 8. Editors' roundtable: Current formulas for P & T Committee success (Part 1).
    Lipman AG; Neu HC; Singh BN; Weintraub M
    Hosp Formul; 1987 Mar; 22(3):288-98. PubMed ID: 10312015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolutionary role of the pharmacy and therapeutics committee in technology assessment.
    Mehr SR
    Manag Care Interface; 2006 Jan; 19(1):42-5. PubMed ID: 16453995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P & T Committee role in advocating rational therapeutics.
    Borreson R
    Hosp Formul; 1986 May; 21(5):590-8. PubMed ID: 10311625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P & T Committee roundtable discussion: Eastern region Pt. II.
    Fine DJ; Guild RT; Kleinmann K; Kupersmith J
    Hosp Formul; 1984 Jul; 19(7):561-4, 568-70. PubMed ID: 10267389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the most difficult DUE your P&T Committee has ever conducted? How did you overcome its obstacles?
    Matanin D
    Hosp Formul; 1992 Feb; 27(2):197-8. PubMed ID: 10116718
    [No Abstract]   [Full Text] [Related]  

  • 13. Minimizing the influence of drug marketing.
    Hester FG
    Hospitals; 1990 Aug; 64(15):80. PubMed ID: 2373503
    [No Abstract]   [Full Text] [Related]  

  • 14. The case for a value-based formulary: striving for total lowest net cost.
    Weart W; Bauman GR
    Manag Care Interface; 2007 Apr; 20(4):42-7. PubMed ID: 17474330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased pressures change P & T Committee makeup.
    Cross M
    Manag Care; 2001 Dec; 10(12):18-9, 23-4, 27-30. PubMed ID: 11794998
    [No Abstract]   [Full Text] [Related]  

  • 16. The evolving role of the P&T committee: enhancing the health technology assessment process.
    Tadlock C
    Manag Care Interface; 2006 Feb; 19(2):14-5. PubMed ID: 16529077
    [No Abstract]   [Full Text] [Related]  

  • 17. Managing the P & T Committee agenda.
    Lipman AG
    Hosp Formul; 1987 Apr; 22(4):331. PubMed ID: 10281366
    [No Abstract]   [Full Text] [Related]  

  • 18. Philosophy and practice of the P & T Committee.
    Lipman AG
    Hosp Formul; 1983 Jun; 18(6):599. PubMed ID: 10260200
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of the microbiology laboratory in guiding formulary decisions.
    Stratton CW
    Hosp Formul; 1988 Aug; 23(8):654-7. PubMed ID: 10312591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician dispensing: P & T Committee implications.
    Weintraub M; Lipman AG
    Hosp Formul; 1987 Jul; 22(7):607, 610. PubMed ID: 10282680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.